Insider Transactions in Q1 2021 at Oyster Point Pharma, Inc. (OYST)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 26
2021
|
Clare Ozawa Director |
SELL
Other acquisition or disposition
|
Indirect |
404,849
-44.0%
|
-
|
|
Mar 26
2021
|
Clare Ozawa Director |
BUY
Other acquisition or disposition
|
Direct |
193
+2.62%
|
-
|
|
Mar 26
2021
|
Clare Ozawa Director |
BUY
Other acquisition or disposition
|
Indirect |
82,491
+50.0%
|
-
|
|
Mar 26
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
404,849
-44.0%
|
-
|
|
Mar 26
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
82,491
+50.0%
|
-
|
|
Mar 26
2021
|
William J Phd Link Director |
BUY
Other acquisition or disposition
|
Indirect |
10,933
+50.0%
|
-
|
|
Feb 24
2021
|
Daniel Lochner Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,109
+20.83%
|
$100,199
$11.51 P/Share
|
|
Feb 19
2021
|
Jeffrey Nau President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+19.65%
|
$10,000
$1.02 P/Share
|
|
Feb 17
2021
|
Clare Ozawa Director |
BUY
Other acquisition or disposition
|
Direct |
372
+5.07%
|
-
|
|
Feb 17
2021
|
Clare Ozawa Director |
SELL
Other acquisition or disposition
|
Indirect |
337,107
-70.9%
|
-
|
|
Feb 17
2021
|
Clare Ozawa Director |
BUY
Other acquisition or disposition
|
Indirect |
12,107
+50.0%
|
-
|
|
Feb 17
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
12,107
-100.0%
|
-
|
|
Feb 17
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
12,107
+50.0%
|
-
|
|
Feb 17
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
325,000
-12.69%
|
-
|
|
Jan 29
2021
|
Daniel Lochner Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,222
+30.54%
|
-
|
|
Jan 29
2021
|
Jeffrey Nau President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
25,898
+45.6%
|
-
|
|
Jan 29
2021
|
John Snisarenko Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,222
+38.11%
|
-
|